NUMETANumerical Methods in Engineering Theory and Applications (conference; UK)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
These national approvals are the first of 20 European countries where the company is seeking authorisation for NUMETA G13E, a parenteral (intravenous) nutrition (PN) product, in 2016.
The company said NUMETA G13E is indicated for PN administration for neonatal patients when oral or enteral nutrition is impossible, insufficient or contraindicated.
NUMETA addresses an important medical need to support neonatal patients who have acute nutritional requirements by providing a balanced formulation of amino acids (protein), glucose (carbohydrates), lipids (fats) and electrolytes in a triple-chamber system that was pioneered by the company.